Prelude Capital Management’s HilleVax HLVX Stock Holding History

Prelude Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,411	Closed	-$26.7K	–	1257
2025 Q2	$26.7K	Sell	13,411 -8,689	-39%	-$15.9K	﹤0.01%	968
2025 Q1	$32K	Buy	22,100 +5,800	+36%	+$10.7K	﹤0.01%	1112
2024 Q4	$33.7K	Buy	+16,300	New	+$30.6K	﹤0.01%	1162
2024 Q3	–	Sell	-18,109	Closed	-$262K	–	1395
2024 Q2	$262K	Buy	18,109 +4,103	+29%	+$56.4K	0.02%	851
2024 Q1	$233K	Buy	+14,006	New	+$224K	0.01%	1031

Prelude Capital Management's HLVX Position: Q3 2025 in Review

Prelude Capital Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 13,411 shares — an estimated $26.7K sold.

Prelude Capital Management first reported a position in HLVX in Q1 2024 and held it in 5 quarters. The position peaked at $262K in Q2 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Prelude Capital Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Prelude Capital Management sold 13,411 HilleVax shares in Q3 2025, an estimated $26.7K.
Prelude Capital Management first reported a position in HilleVax in Q1 2024 and held it in 5 quarters.
Prelude Capital Management's HilleVax position peaked at $262K in Q2 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.